Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial 3'RNA sequencing was performed in 1,733 ...
This study shows that G1 lengthening follows critical dynamics that amplifies cell–cell variation. A novel mathematical model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback